Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
The business side of nuclear cardiology | A new gene therapy for HCM | BP meds & HF | Medtronic's new TAVR approval
Monday, October 16, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Business considerations in the modern nuclear cardiology practice

Robert Hendel, MD, discussed everything from declining reimbursements in cardiology to prior authorization policies in an exclusive new interview. 

READ MORE >
Robert Hendel, MD, Tulane University and former ASNC president, explains the pressing business aspects of nuclear cardiology and why ASNC included business management sessions at its 2023 annual meeting. #ASNC #ASNC23 #ASNC2023
Share on Twitter Share on Facebook Share on Linkedin

Business considerations in the modern nuclear cardiology practice

Share on Twitter Share on Facebook Share on Linkedin
Robert Hendel, MD, Tulane University and former ASNC president, explains the pressing business aspects of nuclear cardiology and why ASNC included business management sessions at its 2023 annual meeting. #ASNC #ASNC23 #ASNC2023
Robert Hendel, MD, discussed everything from declining reimbursements in cardiology to prior authorization policies in an exclusive new interview. 
READ MORE >

Cleveland Clinic treats first patient with new gene therapy for hypertrophic cardiomyopathy

Researchers hopes this first-in-class gene therapy, known as TN-201, can restore the patient’s MYBPC3 levels and eventually lead to disease reversal.

READ MORE >
Specialists at Cleveland Clinic treated a hypertrophic cardiomyopathy patient with a new gene therapy from Tenaya Therapeutics. Researchers hopes this first-in-class gene therapy, known as TN-201, can restore the patient’s MYBPC3 levels and eventually lead to disease reversal.
Share on Twitter Share on Facebook Share on Linkedin

Cleveland Clinic treats first patient with new gene therapy for hypertrophic cardiomyopathy

Share on Twitter Share on Facebook Share on Linkedin
Specialists at Cleveland Clinic treated a hypertrophic cardiomyopathy patient with a new gene therapy from Tenaya Therapeutics. Researchers hopes this first-in-class gene therapy, known as TN-201, can restore the patient’s MYBPC3 levels and eventually lead to disease reversal.
Researchers hopes this first-in-class gene therapy, known as TN-201, can restore the patient’s MYBPC3 levels and eventually lead to disease reversal.
READ MORE >

No, a popular blood pressure medication does not increase heart failure risk, new research confirms

Dihydropyridines such as amlodipine have been the topic of some debate in recent months due to fears they lead to significant side effects. 

READ MORE >
Blood pressure
Share on Twitter Share on Facebook Share on Linkedin

No, a popular blood pressure medication does not increase heart failure risk, new research confirms

Share on Twitter Share on Facebook Share on Linkedin
Blood pressure
Dihydropyridines such as amlodipine have been the topic of some debate in recent months due to fears they lead to significant side effects. 
READ MORE >

Medtronic receives CE mark approval for Evolut FX TAVR system

The self-expanding valve, already approved by the FDA, was designed with three gold markers to boost implanter efficiency, an updated catheter tip and a more flexible delivery system.

READ MORE >
Medtronic's Evolut FX TAVR valve, designed with 3 golden markers that improve alignment.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic receives CE mark approval for Evolut FX TAVR system

Share on Twitter Share on Facebook Share on Linkedin
Medtronic's Evolut FX TAVR valve, designed with 3 golden markers that improve alignment.
The self-expanding valve, already approved by the FDA, was designed with three gold markers to boost implanter efficiency, an updated catheter tip and a more flexible delivery system.
READ MORE >

Featured Articles

One-stop cardiology clinic opens, offering same-day CVD diagnoses

The new healthcare facility is the first of its kind, offering same-day cardiac imaging scans, cardiologist consultations and diagnoses. 

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

One-stop cardiology clinic opens, offering same-day CVD diagnoses

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
The new healthcare facility is the first of its kind, offering same-day cardiac imaging scans, cardiologist consultations and diagnoses. 
READ MORE >

FDA warns Abiomed about ‘significant violations’ related to its Impella heart pumps

The agency said Abiomed did not seek the necessary approvals for one Impella-related device and was slow to act on certain safety concerns. 

READ MORE >
High-risk percutaneous coronary intervention (PCI) with an Impella heart pump is associated with better outcomes, including a significantly higher survival rate, than high-risk PCI with an intra-aortic balloon pump (IABP), according to new findings published in the American Journal of Cardiology. Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock
Share on Twitter Share on Facebook Share on Linkedin

FDA warns Abiomed about ‘significant violations’ related to its Impella heart pumps

Share on Twitter Share on Facebook Share on Linkedin
High-risk percutaneous coronary intervention (PCI) with an Impella heart pump is associated with better outcomes, including a significantly higher survival rate, than high-risk PCI with an intra-aortic balloon pump (IABP), according to new findings published in the American Journal of Cardiology. Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock
The agency said Abiomed did not seek the necessary approvals for one Impella-related device and was slow to act on certain safety concerns. 
READ MORE >

Does X still mark the spot for cardiologists? The risks and benefits of using Twitter in 2023 and beyond

Should interventional cardiologists be using X, the website formerly known as Twitter? A team of specialists explored that very question, sharing its assessment in JSCAI.

READ MORE >
Smartphone mHealth. Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 
Share on Twitter Share on Facebook Share on Linkedin

Does X still mark the spot for cardiologists? The risks and benefits of using Twitter in 2023 and beyond

Share on Twitter Share on Facebook Share on Linkedin
Smartphone mHealth. Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 
Should interventional cardiologists be using X, the website formerly known as Twitter? A team of specialists explored that very question, sharing its assessment in JSCAI.
READ MORE >

How to address staffing shortages in cardiac CT

Eric Williamson, MD, a former SCCT president, examined recruitment and retention strategies for physicians and technologists in the field of cardiac CT. 

READ MORE >
Former SCCT president Eric Williamson, MD, FSCCT, vice chair for radiology informatics and AI at Mayo Clinic, presented the session one staffing challenges and provided insights into recruitment and retention strategies for physicians and technologists in the field. #SCCT #SCCT23 #SCCT2023 #cardiovascularbusiness
Share on Twitter Share on Facebook Share on Linkedin

How to address staffing shortages in cardiac CT

Share on Twitter Share on Facebook Share on Linkedin
Former SCCT president Eric Williamson, MD, FSCCT, vice chair for radiology informatics and AI at Mayo Clinic, presented the session one staffing challenges and provided insights into recruitment and retention strategies for physicians and technologists in the field. #SCCT #SCCT23 #SCCT2023 #cardiovascularbusiness
Eric Williamson, MD, a former SCCT president, examined recruitment and retention strategies for physicians and technologists in the field of cardiac CT. 
READ MORE >

In Case You Missed It

‘We share a common vision’: Private equity-backed cardiology management group partners with MedAxiom, ACC

The group's roster of 17 like-minded cardiology practices now has access to MedAxiom's practice management tools and other key resources. 

READ MORE >
healthcare business deal
Share on Twitter Share on Facebook Share on Linkedin

‘We share a common vision’: Private equity-backed cardiology management group partners with MedAxiom, ACC

Share on Twitter Share on Facebook Share on Linkedin
healthcare business deal
The group's roster of 17 like-minded cardiology practices now has access to MedAxiom's practice management tools and other key resources. 
READ MORE >

Cardiac CT's financial impact on the cardiovascular service line

Implementing cardiac CT can make a big impact across the service line without reducing the use of other modalities. Ginger Biesbrock, MedAxiom's executive vice president, explained these findings in a new video interview.

READ MORE >
Video interviuew with Ginger Biesbrock, DSc, PA-C, FACC, executive vice president of MedAxiom, on the "Financial Impact of Cardiac CT to the Cardiovascular Service Line" report at SCCT 2023. #SCCT #YesCCT #Medaxiom
Share on Twitter Share on Facebook Share on Linkedin

Cardiac CT's financial impact on the cardiovascular service line

Share on Twitter Share on Facebook Share on Linkedin
Video interviuew with Ginger Biesbrock, DSc, PA-C, FACC, executive vice president of MedAxiom, on the "Financial Impact of Cardiac CT to the Cardiovascular Service Line" report at SCCT 2023. #SCCT #YesCCT #Medaxiom
Implementing cardiac CT can make a big impact across the service line without reducing the use of other modalities. Ginger Biesbrock, MedAxiom's executive vice president, explained these findings in a new video interview.
READ MORE >

In Other News

CMS removes national coverage determination for beta-amyloid PET, expanding access to vital imaging exam

Eliminating the previous “coverage with evidence development” requirement allows local MACs to dictate payment for such exams. 

READ MORE >
brain money alzheimer dementia
Share on Twitter Share on Facebook Share on Linkedin

CMS removes national coverage determination for beta-amyloid PET, expanding access to vital imaging exam

Share on Twitter Share on Facebook Share on Linkedin
brain money alzheimer dementia
Eliminating the previous “coverage with evidence development” requirement allows local MACs to dictate payment for such exams. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup